XERS |
Xeris Biopharma Holdings, Inc. |
Jun 5, 2024 |
1 |
$0 |
4 |
Jun 5, 2024 |
Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Mar 15, 2024 |
1 |
$0 |
4 |
Apr 1, 2024 |
Director |
LH |
LABORATORY CORP OF AMERICA HOLDINGS |
Feb 6, 2024 |
3 |
$0 |
4 |
Feb 8, 2024 |
Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Jun 7, 2023 |
1 |
$0 |
4 |
Jun 7, 2023 |
Director |
VERO |
Venus Concept Inc. |
Mar 24, 2023 |
1 |
$0 |
4 |
Mar 28, 2023 |
Director |
LH |
LABORATORY CORP OF AMERICA HOLDINGS |
Feb 11, 2023 |
2 |
$0 |
4 |
Feb 14, 2023 |
Director |
LH |
LABORATORY CORP OF AMERICA HOLDINGS |
Feb 7, 2023 |
1 |
$0 |
4 |
Feb 9, 2023 |
Director |
ALIM |
ALIMERA SCIENCES INC |
Jan 4, 2023 |
1 |
$0 |
4 |
Jan 6, 2023 |
Director |
VERO |
Venus Concept Inc. |
Nov 18, 2022 |
1 |
$670K |
4 |
Nov 22, 2022 |
Director, 10%+ Owner |
XERS |
Xeris Biopharma Holdings, Inc. |
Jun 8, 2022 |
2 |
$0 |
4 |
Jun 9, 2022 |
Director |
VERO |
Venus Concept Inc. |
Mar 25, 2022 |
1 |
$0 |
4 |
Mar 28, 2022 |
Director |
LH |
LABORATORY CORP OF AMERICA HOLDINGS |
Feb 11, 2022 |
1 |
$0 |
4 |
Feb 15, 2022 |
Director |
LH |
LABORATORY CORP OF AMERICA HOLDINGS |
Feb 2, 2022 |
2 |
$0 |
4 |
Feb 4, 2022 |
Director |
VERO |
Venus Concept Inc. |
Dec 15, 2021 |
1 |
$2M |
4 |
Dec 17, 2021 |
Director, 10%+ Owner |
ALIM |
ALIMERA SCIENCES INC |
Nov 2, 2021 |
1 |
$0 |
4 |
Nov 4, 2021 |
Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Oct 5, 2021 |
7 |
$46.6K |
4/A |
Oct 8, 2021 |
Director |
SBBP |
Strongbridge Biopharma plc |
Oct 5, 2021 |
2 |
$0 |
4 |
Oct 6, 2021 |
Director |
XERS |
Xeris Biopharma Holdings, Inc. |
Oct 5, 2021 |
0 |
$0 |
3 |
Oct 5, 2021 |
Director |
SBBP |
Strongbridge Biopharma plc |
Oct 1, 2021 |
1 |
-$36.6K |
4 |
Oct 5, 2021 |
Director |
SBBP |
Strongbridge Biopharma plc |
May 18, 2021 |
1 |
$0 |
4 |
May 18, 2021 |
Director |
SBBP |
Strongbridge Biopharma plc |
May 14, 2021 |
1 |
-$45.1K |
4 |
May 17, 2021 |
Director |